Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 41 entries
Sorted by: Best Match Show Resources per page
Detection of Genomic Structural Variants from Next-Generation Sequencing Data.

Frontiers in bioengineering and biotechnology

Tattini L, D'Aurizio R, Magi A.
PMID: 26161383
Front Bioeng Biotechnol. 2015 Jun 25;3:92. doi: 10.3389/fbioe.2015.00092. eCollection 2015.

Structural variants are genomic rearrangements larger than 50 bp accounting for around 1% of the variation among human genomes. They impact on phenotypic diversity and play a role in various diseases including neurological/neurocognitive disorders and cancer development and progression....

Cite
Tattini L, D'Aurizio R, Magi A. Detection of Genomic Structural Variants from Next-Generation Sequencing Data. Front Bioeng Biotechnol. 2015;3:92doi: 10.3389/fbioe.2015.00092.
Tattini, L., D'Aurizio, R., & Magi, A. (2015). Detection of Genomic Structural Variants from Next-Generation Sequencing Data. Frontiers in bioengineering and biotechnology, 392. https://doi.org/10.3389/fbioe.2015.00092
Tattini, Lorenzo, et al. "Detection of Genomic Structural Variants from Next-Generation Sequencing Data." Frontiers in bioengineering and biotechnology vol. 3 (2015): 92. doi: https://doi.org/10.3389/fbioe.2015.00092
Tattini L, D'Aurizio R, Magi A. Detection of Genomic Structural Variants from Next-Generation Sequencing Data. Front Bioeng Biotechnol. 2015 Jun 25;3:92. doi: 10.3389/fbioe.2015.00092. eCollection 2015. PMID: 26161383; PMCID: PMC4479793.
Copy Download .nbib Format: NLM
Establishment of the upper reference limit for thyroid peroxidase autoantibodies according to the guidelines proposed by the National Academy of Clinical Biochemistry: comparison of five different automated methods.

Auto- immunity highlights

D'Aurizio F, Metus P, Polizzi Anselmo A, Villalta D, Ferrari A, Castello R, Giani G, Tonutti E, Bizzaro N, Tozzoli R.
PMID: 26275915
Auto Immun Highlights. 2015 Dec;6(3):31-7. doi: 10.1007/s13317-015-0070-x. Epub 2015 Aug 15.

AIM OF THE STUDY: The estimation of the upper reference limit (URL) for autoantibodies against thyroid peroxidase (TPOAbs) is a controversial issue, because of an uncertainty associated with the criteria used to correctly define the reference population. In addition,...

Cite
D'Aurizio F, Metus P, Polizzi Anselmo A, et al. Establishment of the upper reference limit for thyroid peroxidase autoantibodies according to the guidelines proposed by the National Academy of Clinical Biochemistry: comparison of five different automated methods. Auto Immun Highlights. 2015;6(3):31-7doi: 10.1007/s13317-015-0070-x.
D'Aurizio, F., Metus, P., Polizzi Anselmo, A., Villalta, D., Ferrari, A., Castello, R., Giani, G., Tonutti, E., Bizzaro, N., & Tozzoli, R. (2015). Establishment of the upper reference limit for thyroid peroxidase autoantibodies according to the guidelines proposed by the National Academy of Clinical Biochemistry: comparison of five different automated methods. Auto- immunity highlights, 6(3), 31-7. https://doi.org/10.1007/s13317-015-0070-x
D'Aurizio, Federica, et al. "Establishment of the upper reference limit for thyroid peroxidase autoantibodies according to the guidelines proposed by the National Academy of Clinical Biochemistry: comparison of five different automated methods." Auto- immunity highlights vol. 6,3 (2015): 31-7. doi: https://doi.org/10.1007/s13317-015-0070-x
D'Aurizio F, Metus P, Polizzi Anselmo A, Villalta D, Ferrari A, Castello R, Giani G, Tonutti E, Bizzaro N, Tozzoli R. Establishment of the upper reference limit for thyroid peroxidase autoantibodies according to the guidelines proposed by the National Academy of Clinical Biochemistry: comparison of five different automated methods. Auto Immun Highlights. 2015 Dec;6(3):31-7. doi: 10.1007/s13317-015-0070-x. Epub 2015 Aug 15. PMID: 26275915; PMCID: PMC4633414.
Copy Download .nbib Format: NLM
Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease.

Movement disorders clinical practice

Standaert DG, Rodriguez RL, Slevin JT, Lobatz M, Eaton S, Chatamra K, Facheris MF, Hall C, Sail K, Jalundhwala YJ, Benesh J.
PMID: 29242809
Mov Disord Clin Pract. 2017 Nov-Dec;4(6):829-837. doi: 10.1002/mdc3.12526. Epub 2017 Sep 20.

BACKGROUND: Levodopa-carbidopa intestinal gel (LCIG; carbidopa-levodopa enteral suspension in the United States), delivered via percutaneous gastrojejunostomy (PEG-J) and titrated in the inpatient setting, is an established treatment option for advanced Parkinson's disease (PD) patients with motor fluctuations. However, long-term...

Cite
Standaert DG, Rodriguez RL, Slevin JT, et al. Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease. Mov Disord Clin Pract. 2017;4(6):829-837doi: 10.1002/mdc3.12526.
Standaert, D. G., Rodriguez, R. L., Slevin, J. T., Lobatz, M., Eaton, S., Chatamra, K., Facheris, M. F., Hall, C., Sail, K., Jalundhwala, Y. J., & Benesh, J. (2017). Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease. Movement disorders clinical practice, 4(6), 829-837. https://doi.org/10.1002/mdc3.12526
Standaert, David G, et al. "Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease." Movement disorders clinical practice vol. 4,6 (2017): 829-837. doi: https://doi.org/10.1002/mdc3.12526
Standaert DG, Rodriguez RL, Slevin JT, Lobatz M, Eaton S, Chatamra K, Facheris MF, Hall C, Sail K, Jalundhwala YJ, Benesh J. Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease. Mov Disord Clin Pract. 2017 Nov-Dec;4(6):829-837. doi: 10.1002/mdc3.12526. Epub 2017 Sep 20. PMID: 29242809; PMCID: PMC5724683.
Copy Download .nbib Format: NLM
Retraction Note: Insomnia, sleepiness, anxiety and depression among different types of gamers in African countries.

Scientific reports

Sosso FAE, Kuss DJ, Vandelanotte C, Jasso-Medrano JL, Husain ME, Curcio G, Papadopoulos D, Aseem A, Bhati P, Lopez-Rosales F, Becerra JR, D'Aurizio G, Mansouri H, Khoury T, Campbell M, Toth AJ.
PMID: 32499575
Sci Rep. 2020 Jun 04;10(1):9256. doi: 10.1038/s41598-020-66798-w.

This Article has been retracted.

Cite
Sosso FAE, Kuss DJ, Vandelanotte C, et al. Retraction Note: Insomnia, sleepiness, anxiety and depression among different types of gamers in African countries. Sci Rep. 2020;10(1):9256doi: 10.1038/s41598-020-66798-w.
Sosso, F. A. E., Kuss, D. J., Vandelanotte, C., Jasso-Medrano, J. L., Husain, M. E., Curcio, G., Papadopoulos, D., Aseem, A., Bhati, P., Lopez-Rosales, F., Becerra, J. R., D'Aurizio, G., Mansouri, H., Khoury, T., Campbell, M., & Toth, A. J. (2020). Retraction Note: Insomnia, sleepiness, anxiety and depression among different types of gamers in African countries. Scientific reports, 10(1), 9256. https://doi.org/10.1038/s41598-020-66798-w
Sosso, F A Etindele, et al. "Retraction Note: Insomnia, sleepiness, anxiety and depression among different types of gamers in African countries." Scientific reports vol. 10,1 (2020): 9256. doi: https://doi.org/10.1038/s41598-020-66798-w
Sosso FAE, Kuss DJ, Vandelanotte C, Jasso-Medrano JL, Husain ME, Curcio G, Papadopoulos D, Aseem A, Bhati P, Lopez-Rosales F, Becerra JR, D'Aurizio G, Mansouri H, Khoury T, Campbell M, Toth AJ. Retraction Note: Insomnia, sleepiness, anxiety and depression among different types of gamers in African countries. Sci Rep. 2020 Jun 04;10(1):9256. doi: 10.1038/s41598-020-66798-w. PMID: 32499575; PMCID: PMC7272647.
Copy Download .nbib Format: NLM
Safer Attitude to Risky Decision-Making in Premanifest Huntington's Disease Subjects.

Frontiers in psychology

D'Aurizio G, Migliore S, Curcio G, Squitieri F.
PMID: 31057466
Front Psychol. 2019 Apr 16;10:846. doi: 10.3389/fpsyg.2019.00846. eCollection 2019.

Huntington's disease (HD) is an inherited neurodegenerative disorder characterized by involuntary, jerky movements, incoordination, behavioral changes and subtle executive and cognitive impairment starting before motor symptoms. Our study aimed to assess the risky decision-making process in premanifest (pre) HD...

Cite
D'Aurizio G, Migliore S, Curcio G, et al. Safer Attitude to Risky Decision-Making in Premanifest Huntington's Disease Subjects. Front Psychol. 2019;10:846doi: 10.3389/fpsyg.2019.00846.
D'Aurizio, G., Migliore, S., Curcio, G., & Squitieri, F. (2019). Safer Attitude to Risky Decision-Making in Premanifest Huntington's Disease Subjects. Frontiers in psychology, 10846. https://doi.org/10.3389/fpsyg.2019.00846
D'Aurizio, Giulia, et al. "Safer Attitude to Risky Decision-Making in Premanifest Huntington's Disease Subjects." Frontiers in psychology vol. 10 (2019): 846. doi: https://doi.org/10.3389/fpsyg.2019.00846
D'Aurizio G, Migliore S, Curcio G, Squitieri F. Safer Attitude to Risky Decision-Making in Premanifest Huntington's Disease Subjects. Front Psychol. 2019 Apr 16;10:846. doi: 10.3389/fpsyg.2019.00846. eCollection 2019. PMID: 31057466; PMCID: PMC6477566.
Copy Download .nbib Format: NLM
Using XCAVATOR and EXCAVATOR2 to Identify CNVs from WGS, WES, and TS Data.

Current protocols in human genetics

D'Aurizio R, Semeraro R, Magi A.
PMID: 29975818
Curr Protoc Hum Genet. 2018 Jul 05;e65. doi: 10.1002/cphg.65. Epub 2018 Jul 05.

Copy Number Variants (CNVs) are structural rearrangements contributing to phenotypic variation but also associated with many disease states. In recent years, the identification of CNVs from high-throughput sequencing experiments has become a common practice for both research and clinical...

Cite
D'Aurizio R, Semeraro R, Magi A. Using XCAVATOR and EXCAVATOR2 to Identify CNVs from WGS, WES, and TS Data. Curr Protoc Hum Genet. 2018;e65doi: 10.1002/cphg.65.
D'Aurizio, R., Semeraro, R., & Magi, A. (2018). Using XCAVATOR and EXCAVATOR2 to Identify CNVs from WGS, WES, and TS Data. Current protocols in human genetics, e65. https://doi.org/10.1002/cphg.65
D'Aurizio, Romina, et al. "Using XCAVATOR and EXCAVATOR2 to Identify CNVs from WGS, WES, and TS Data." Current protocols in human genetics vol. (2018): e65. doi: https://doi.org/10.1002/cphg.65
D'Aurizio R, Semeraro R, Magi A. Using XCAVATOR and EXCAVATOR2 to Identify CNVs from WGS, WES, and TS Data. Curr Protoc Hum Genet. 2018 Jul 05;e65. doi: 10.1002/cphg.65. Epub 2018 Jul 05. PMID: 29975818.
Copy Download .nbib Format: NLM
[No title available]

The Lancet. Oncology

Strosberg JR, Caplin ME, Kunz PL, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, Wolin EM, Yao JC, Pavel ME, Grande E, Van Cutsem E, Seregni E, Duarte H, Gericke G, Bartalotta A, Mariani MF, Demange A, Mutevelic S, Krenning EP.
PMID: 34793718
Lancet Oncol. 2021 Dec;22(12):1752-1763. doi: 10.1016/S1470-2045(21)00572-6. Epub 2021 Nov 15.

FUNDING: Advanced Accelerator Applications, a Novartis company.

Cite
Strosberg JR, Caplin ME, Kunz PL, et al. . Lancet Oncol. 2021;22(12):1752-1763doi: 10.1016/S1470-2045(21)00572-6.
Strosberg, J. R., Caplin, M. E., Kunz, P. L., Ruszniewski, P. B., Bodei, L., Hendifar, A., Mittra, E., Wolin, E. M., Yao, J. C., Pavel, M. E., Grande, E., Van Cutsem, E., Seregni, E., Duarte, H., Gericke, G., Bartalotta, A., Mariani, M. F., Demange, A., Mutevelic, S., Krenning, E. P. (2021). . The Lancet. Oncology, 22(12), 1752-1763. https://doi.org/10.1016/S1470-2045(21)00572-6
Strosberg, Jonathan R, et al. "." The Lancet. Oncology vol. 22,12 (2021): 1752-1763. doi: https://doi.org/10.1016/S1470-2045(21)00572-6
Strosberg JR, Caplin ME, Kunz PL, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, Wolin EM, Yao JC, Pavel ME, Grande E, Van Cutsem E, Seregni E, Duarte H, Gericke G, Bartalotta A, Mariani MF, Demange A, Mutevelic S, Krenning EP. . Lancet Oncol. 2021 Dec;22(12):1752-1763. doi: 10.1016/S1470-2045(21)00572-6. Epub 2021 Nov 15. PMID: 34793718.
Copy Download .nbib Format: NLM
A night of sleep deprivation alters brain connectivity and affects specific executive functions.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Pesoli M, Rucco R, Liparoti M, Lardone A, D'Aurizio G, Minino R, Troisi Lopez E, Paccone A, Granata C, Curcio G, Sorrentino G, Mandolesi L, Sorrentino P.
PMID: 34244891
Neurol Sci. 2021 Jul 10; doi: 10.1007/s10072-021-05437-2. Epub 2021 Jul 10.

Sleep is a fundamental physiological process necessary for efficient cognitive functioning especially in relation to memory consolidation and executive functions, such as attentional and switching abilities. The lack of sleep strongly alters the connectivity of some resting-state networks, such...

Cite
Pesoli M, Rucco R, Liparoti M, et al. A night of sleep deprivation alters brain connectivity and affects specific executive functions. Neurol Sci. 2021;doi: 10.1007/s10072-021-05437-2.
Pesoli, M., Rucco, R., Liparoti, M., Lardone, A., D'Aurizio, G., Minino, R., Troisi Lopez, E., Paccone, A., Granata, C., Curcio, G., Sorrentino, G., Mandolesi, L., & Sorrentino, P. (2021). A night of sleep deprivation alters brain connectivity and affects specific executive functions. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, . https://doi.org/10.1007/s10072-021-05437-2
Pesoli, Matteo, et al. "A night of sleep deprivation alters brain connectivity and affects specific executive functions." Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology vol. (2021). doi: https://doi.org/10.1007/s10072-021-05437-2
Pesoli M, Rucco R, Liparoti M, Lardone A, D'Aurizio G, Minino R, Troisi Lopez E, Paccone A, Granata C, Curcio G, Sorrentino G, Mandolesi L, Sorrentino P. A night of sleep deprivation alters brain connectivity and affects specific executive functions. Neurol Sci. 2021 Jul 10; doi: 10.1007/s10072-021-05437-2. Epub 2021 Jul 10. PMID: 34244891.
Copy Download .nbib Format: NLM
Intensive Environmental Surveillance Plan for .

Foods (Basel, Switzerland)

Centorotola G, Guidi F, D'Aurizio G, Salini R, Di Domenico M, Ottaviani D, Petruzzelli A, Fisichella S, Duranti A, Tonucci F, Acciari VA, Torresi M, Pomilio F, Blasi G.
PMID: 34441721
Foods. 2021 Aug 20;10(8). doi: 10.3390/foods10081944.

No abstract available.

Cite
Centorotola G, Guidi F, D'Aurizio G, et al. Intensive Environmental Surveillance Plan for . Foods. 2021;10(8)doi: 10.3390/foods10081944.
Centorotola, G., Guidi, F., D'Aurizio, G., Salini, R., Di Domenico, M., Ottaviani, D., Petruzzelli, A., Fisichella, S., Duranti, A., Tonucci, F., Acciari, V. A., Torresi, M., Pomilio, F., & Blasi, G. (2021). Intensive Environmental Surveillance Plan for . Foods (Basel, Switzerland), 10(8), . https://doi.org/10.3390/foods10081944
Centorotola, Gabriella, et al. "Intensive Environmental Surveillance Plan for ." Foods (Basel, Switzerland) vol. 10,8 (2021). doi: https://doi.org/10.3390/foods10081944
Centorotola G, Guidi F, D'Aurizio G, Salini R, Di Domenico M, Ottaviani D, Petruzzelli A, Fisichella S, Duranti A, Tonucci F, Acciari VA, Torresi M, Pomilio F, Blasi G. Intensive Environmental Surveillance Plan for . Foods. 2021 Aug 20;10(8). doi: 10.3390/foods10081944. PMID: 34441721; PMCID: PMC8392342.
Copy Download .nbib Format: NLM
Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid Carcinoma.

The Journal of clinical endocrinology and metabolism

Giovanella L, Garo ML, Ceriani L, Paone G, Campenni' A, D'Aurizio F.
PMID: 34382653
J Clin Endocrinol Metab. 2021 Nov 19;106(12):3634-3643. doi: 10.1210/clinem/dgab564.

CONTEXT: Calcitonin (CT) measurement is pivotal in the management of medullary thyroid carcinoma (MTC), but several pitfalls can affect its reliability. Procalcitonin (ProCT) has been reported as a promising alternative MTC tumor marker.OBJECTIVE: This study aimed to determine the...

Cite
Giovanella L, Garo ML, Ceriani L, et al. Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid Carcinoma. J Clin Endocrinol Metab. 2021;106(12):3634-3643doi: 10.1210/clinem/dgab564.
Giovanella, L., Garo, M. L., Ceriani, L., Paone, G., Campenni', A., & D'Aurizio, F. (2021). Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid Carcinoma. The Journal of clinical endocrinology and metabolism, 106(12), 3634-3643. https://doi.org/10.1210/clinem/dgab564
Giovanella, Luca, et al. "Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid Carcinoma." The Journal of clinical endocrinology and metabolism vol. 106,12 (2021): 3634-3643. doi: https://doi.org/10.1210/clinem/dgab564
Giovanella L, Garo ML, Ceriani L, Paone G, Campenni' A, D'Aurizio F. Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid Carcinoma. J Clin Endocrinol Metab. 2021 Nov 19;106(12):3634-3643. doi: 10.1210/clinem/dgab564. PMID: 34382653.
Copy Download .nbib Format: NLM
A controlled randomised trial of t-UDCA as adjuvant to interferon for treatment of chronic hepatitis C: an interferon sparing effect of t-UDCA.

Hepatology research : the official journal of the Japan Society of Hepatology

Gracielle P, Roberta S, Ornella B, Luciana D, Alessandro R, Daniela Q, Gianpaolo L, Grazia D, Lamberto B, Anna C, Maurizio F, Alberto L.
PMID: 12191671
Hepatol Res. 2002 Aug;23(4):227. doi: 10.1016/s1386-6346(02)00007-4.

BACKGROUND: Combination of the cytoprotective effect of tauro-ursodeoxycholic acid (t-UDCA) with the antiviral effect of interferon may be more effective than interferon alone for treatment of chronic hepatitis C. METHODS: We randomised 106 patients with chronic hepatitis C to...

Cite
Gracielle P, Roberta S, Ornella B, et al. A controlled randomised trial of t-UDCA as adjuvant to interferon for treatment of chronic hepatitis C: an interferon sparing effect of t-UDCA. Hepatol Res. 2002;23(4):227doi: 10.1016/s1386-6346(02)00007-4.
Gracielle, P., Roberta, S., Ornella, B., Luciana, D., Alessandro, R., Daniela, Q., Gianpaolo, L., Grazia, D., Lamberto, B., Anna, C., Maurizio, F., & Alberto, L. (2002). A controlled randomised trial of t-UDCA as adjuvant to interferon for treatment of chronic hepatitis C: an interferon sparing effect of t-UDCA. Hepatology research : the official journal of the Japan Society of Hepatology, 23(4), 227. https://doi.org/10.1016/s1386-6346(02)00007-4
Gracielle, Pigozzi, et al. "A controlled randomised trial of t-UDCA as adjuvant to interferon for treatment of chronic hepatitis C: an interferon sparing effect of t-UDCA." Hepatology research : the official journal of the Japan Society of Hepatology vol. 23,4 (2002): 227. doi: https://doi.org/10.1016/s1386-6346(02)00007-4
Gracielle P, Roberta S, Ornella B, Luciana D, Alessandro R, Daniela Q, Gianpaolo L, Grazia D, Lamberto B, Anna C, Maurizio F, Alberto L. A controlled randomised trial of t-UDCA as adjuvant to interferon for treatment of chronic hepatitis C: an interferon sparing effect of t-UDCA. Hepatol Res. 2002 Aug;23(4):227. doi: 10.1016/s1386-6346(02)00007-4. PMID: 12191671.
Copy Download .nbib Format: NLM
Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves' disease.

Auto- immunity highlights

Villalta D, D'Aurizio F, Da Re M, Ricci D, Latrofa F, Tozzoli R.
PMID: 29435670
Auto Immun Highlights. 2018 Feb 12;9(1):3. doi: 10.1007/s13317-018-0102-4.

PURPOSE: Thyrotropin receptor (TSHR) autoantibodies (TRAbs) are a hallmark of Graves' disease (GD). The aim of this study was to evaluate the diagnostic accuracy of a new third generation automatic fluorescence enzyme immunoassay for TRAb measurement in GD, in...

Cite
Villalta D, D'Aurizio F, Da Re M, et al. Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves' disease. Auto Immun Highlights. 2018;9(1):3doi: 10.1007/s13317-018-0102-4.
Villalta, D., D'Aurizio, F., Da Re, M., Ricci, D., Latrofa, F., & Tozzoli, R. (2018). Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves' disease. Auto- immunity highlights, 9(1), 3. https://doi.org/10.1007/s13317-018-0102-4
Villalta, Danilo, et al. "Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves' disease." Auto- immunity highlights vol. 9,1 (2018): 3. doi: https://doi.org/10.1007/s13317-018-0102-4
Villalta D, D'Aurizio F, Da Re M, Ricci D, Latrofa F, Tozzoli R. Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves' disease. Auto Immun Highlights. 2018 Feb 12;9(1):3. doi: 10.1007/s13317-018-0102-4. PMID: 29435670; PMCID: PMC5809681.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 41 entries